HIV begins with symptoms like fever, sore throat, and chills. Tetra Images/Getty Images The first stage of HIV is called acute HIV and causes flu-like symptoms like fever, chills, and fatigue. During ...
Gilead Sciences said on Monday its experimental HIV treatment met the main goal and was found to be statistically ...
With a second late-stage trial win for its investigational HIV combo in the books, Gilead Sciences is moving full steam ahead ...
Antiretroviral therapy can prevent HIV from progressing, especially when a person starts taking it early. People with HIV who receive this treatment can live long, healthy lives. Their life ...
An early trial for an experimental HIV vaccine candidate has shown promising results. 97% of recipients in a phase 1 study showed immune system activity in response to the vaccine. But there's a long ...
Gilead Sciences said on Monday its experimental HIV treatment was found to be statistically non-inferior to its top-selling ...
The human immunodeficiency virus (HIV) directly impacts the brain in the early stages of the infection, researchers have found. Stellenbosch University (SU) researchers have discovered that the human ...
Zacks Investment Research on MSN
GILD's bictegravir and lenacapavir regimen for HIV meets primary goal
Gilead Sciences, Inc. GILD announced that the investigational single-tablet regimen of bictegravir and lenacapavir for the ...
Impaired antibody response in an AIDS patient compromised the accuracy of the test. The OraQuick Advance Rapid HIV-1 Antibody Test has transformed HIV testing from a cumbersome process to a rapid ...
People with HIV with early-stage cancers are up to four times more likely to go untreated for cancer
People with HIV who are diagnosed with cancer are two to four times more likely to go untreated for their cancer compared to uninfected cancer patients, according to a new, large retrospective study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback